Person:
Guillén Grima, Francisco

Profile Picture

Email Address

person.page.identifierURI

https://academica-e.unavarra.es/handle/2454/49219

Birth Date

Research Projects

Organizational Units

Job Title

Last Name

Guillén Grima

First Name

Francisco

person.page.departamento

Ciencias de la Salud

person.page.instituteName

ORCID

0000-0001-9749-8076

person.page.upna

352

Name

Filters

2017 - 20183
Reset filters

Settings

Start date: 2010 × End date: 2019 × Subject: Alzheimer’s disease ×

Search Results

Now showing 1 - 3 of 3
  • Thumbnail Image
    PublicationOpen Access
    Trends in hospital morbidity from Alzheimer's disease in the European Union, 2000-2014
    (SAGE, 2018) Niu, Hao; Álvarez Álvarez, Ismael; Aguinaga Ontoso, Inés; Guillén Grima, Francisco; Ciencias de la Salud; Osasun Zientziak
    Background: Alzheimer’s disease (AD) has become a concerning public health issue. We aimed to analyse the trends of hospital morbidity from AD in the European Union (EU) in the period 2000-2014. Methods: Data from hospital discharges of men and women over 50 years old hospitalised from AD in the EU were extracted from Eurostat database. We tested for secular trends computing the annual percent change, and identifying significant changes in the linear slope of the trend. Results: Hospital morbidity from AD showed a 0.8% (95% confidence intervals -2.2, 0.6) slight declining trend in the EU. In men and women, we recorded a -0.5% and -1.0% decrease in hospital morbidity rates, respectively. Several countries showed changing trends during the study period. Conclusion: AD hospital morbidity has slightly declined in the entire EU in the past years. Eastern European countries showed steadily increasing trends, whereas in western and Mediterranean countries rates decreased or levelled off.
  • Thumbnail Image
    PublicationOpen Access
    Trends of mortality from Alzheimer's disease in the European Union, 1994-2013
    (Wiley, 2017) Niu, Hao; Álvarez Álvarez, Ismael; Guillén Grima, Francisco; Jamal Saad Al-Rahamneh, Moad; Aguinaga Ontoso, Inés; Ciencias de la Salud; Osasun Zientziak
    Background: In many countries, Alzheimer’s disease (AD) has gradually become a relevant disease in elderly populations. The aim of this study was to analyse trends of mortality caused by AD in the 28 member countries in the European Union (EU) over the last two decades. Methods: We extracted data for AD deaths for the period 1994-2013 in the EU from the Eurostat and World Health Organization database. Age-standardised mortality rates per 100,000 were computed. Joinpoint regression was used to analyse the trends and compute the annual percent change (APC) in the EU as a whole and by country. Analyses by gender and by European regions were conducted. Results: Throughout the study period, mortality from AD has risen in the EU. Most of the countries showed upward trends, with the sharpest increases in Slovakia, Lithuania and Romania. In men and women, we recorded a 4.7% and 6.0% statistically significant increase in mortality rates in the whole EU, respectively. Several countries showed changing trends during the study period. According to the regional analysis, Northern and Eastern countries showed the steepest increases, while in the latter years in Western countries mortality has declined. Conclusions: Our findings provide evidence that AD mortality has increased in the EU, especially in Eastern and Northern European countries and in the female population. Our results could be a reference for the development of primary prevention policies.
  • Thumbnail Image
    PublicationOpen Access
    Prevalence and incidence of Alzheimer's disease in Europe: a meta-analysis
    (Elsevier España, 2017) Niu, Hao; Álvarez Álvarez, Ismael; Guillén Grima, Francisco; Aguinaga Ontoso, Inés; Ciencias de la Salud; Osasun Zientziak
    Background: A disease of unknown aetiology, Alzheimer’s disease (AD) is the most common type of dementia. As the elderly population grows worldwide, the number of patients with AD also increases rapidly. The aim of this meta-analysis is to evaluate the prevalence and incidence of AD in Europe. Methodology: We conducted a literature search on Medline, Scopus, and CINAHL Complete using the keywords ‘‘Alzheimer’’, ‘‘Alzheimer’s disease’’, and ‘‘AD’’ combined with ‘‘prevalence’’, ‘‘incidence’’, and ‘‘epidemiology’’. A Bayesian random effects model with 95% credible intervals was used. The I 2 statistic was applied to assess heterogeneity. Results: The prevalence of Alzheimer’s disease in Europe was estimated at 5.05% (95% CI, 4.73-5.39). The prevalence in men was 3.31% (95% CI, 2.85-3.80) and in women, 7.13% (95% CI, 6.56-7.72), and increased with age. The incidence of Alzheimer’s disease in Europe was 11.08 per 1000 person-years (95% CI, 10.30-11.89). Broken down by sex, it was 7.02 per 1000 person-years (95% CI, 6.06-8.05) in men and 13.25 per 1000 person-years (95% CI, 12.05-14.51) in women; again these rates increased with age. Conclusions: The results of our meta-analysis allow a better grasp of the impact of this disease in Europe.